Share story
Capital

GeoVax files for offering of 29,585,798 shares or substitute warrants

GeoVax Labs filed a preliminary prospectus on November 3 for an underwritten offering of 29,585,798 common shares, with pre-funded warrants available in place of shares. The clinical-stage biotechnology company develops vaccines and immunotherapies and identifies its GEO-MVA poxvirus vaccine candidate as its near-term development priority. The prospectus uses an assumed price of $0.169 per share; the final price will be negotiated with underwriter E.F. Hutton. Securities cannot be sold until the registration statement becomes effective.
Sources
SEC EDGAR
Published by Tech & Business, a media brand covering technology and business. This story was sourced from SEC EDGAR and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Infrastructure
Infrastructure

Google plans $15B Malaysian data center and cloud investment

Google plans to spend $15B in Malaysia during 2027 and 2028 on data centers, cloud operations, water supplies, power generation and training, The Next Web reports. Alphabet chief investment officer Ruth Porat announced the plan at an event in Kuala Lumpur.

The Next Web
Infrastructure Capital
Infrastructure Capital

Return secures €835 million financing for German battery storage

Energy storage company Return has secured €835 million in portfolio financing underwritten by Deutsche Bank and Rabobank to expand in Germany. The initial framework covers three battery storage projects with a combined capacity of 117 MW.

EU-Startups
Capital AI
Capital AI

Pliant raises $80M for expansion and AI payment workflows

Pliant raised an $80M Series C led by Seaya Nova and Speedinvest, the Berlin fintech said Wednesday. The funding will support expansion in the US and Canada, entry into additional markets and its AI roadmap.

The Next Web